BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35328443)

  • 1. Dedifferentiation of Human Cardiac Myofibroblasts Is Independent of Activation of COX-2/PGE
    Luu VT; Phan S; Jin ZQ
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of the Transcriptome by Prostaglandin E2 during Myofibroblast Dedifferentiation.
    Wettlaufer SH; Scott JP; McEachin RC; Peters-Golden M; Huang SK
    Am J Respir Cell Mol Biol; 2016 Jan; 54(1):114-27. PubMed ID: 26098591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung myofibroblasts are characterized by down-regulated cyclooxygenase-2 and its main metabolite, prostaglandin E2.
    Gabasa M; Royo D; Molina-Molina M; Roca-Ferrer J; Pujols L; Picado C; Xaubet A; Pereda J
    PLoS One; 2013; 8(6):e65445. PubMed ID: 23755232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of myofibroblast differentiation by prostaglandin E(2).
    Garrison G; Huang SK; Okunishi K; Scott JP; Kumar Penke LR; Scruggs AM; Peters-Golden M
    Am J Respir Cell Mol Biol; 2013 May; 48(5):550-8. PubMed ID: 23470625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
    Cho N; Razipour SE; McCain ML
    Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E2 inhibits fibroblast to myofibroblast transition via E. prostanoid receptor 2 signaling and cyclic adenosine monophosphate elevation.
    Kolodsick JE; Peters-Golden M; Larios J; Toews GB; Thannickal VJ; Moore BB
    Am J Respir Cell Mol Biol; 2003 Nov; 29(5):537-44. PubMed ID: 12738687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E2 inhibits α-smooth muscle actin transcription during myofibroblast differentiation via distinct mechanisms of modulation of serum response factor and myocardin-related transcription factor-A.
    Penke LR; Huang SK; White ES; Peters-Golden M
    J Biol Chem; 2014 Jun; 289(24):17151-62. PubMed ID: 24802754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal Human Lung Epithelial Cells Inhibit Transforming Growth Factor-β Induced Myofibroblast Differentiation via Prostaglandin E2.
    Epa AP; Thatcher TH; Pollock SJ; Wahl LA; Lyda E; Kottmann RM; Phipps RP; Sime PJ
    PLoS One; 2015; 10(8):e0135266. PubMed ID: 26248335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myofibroblast dedifferentiation proceeds via distinct transcriptomic and phenotypic transitions.
    Fortier SM; Penke LR; King D; Pham TX; Ligresti G; Peters-Golden M
    JCI Insight; 2021 Mar; 6(6):. PubMed ID: 33561015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of endogenous prostaglandin E2 in tubular epithelial regeneration through inhibition of apoptosis and epithelial-mesenchymal transition in cisplatin-induced rat renal lesions.
    Yamamoto E; Izawa T; Juniantito V; Kuwamura M; Sugiura K; Takeuchi T; Yamate J
    Histol Histopathol; 2010 Aug; 25(8):995-1007. PubMed ID: 20552550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic activation of human cardiac fibroblasts in vitro attenuates the reversibility of the myofibroblast phenotype.
    Hall C; Law JP; Reyat JS; Cumberland MJ; Hang S; Vo NTN; Raniga K; Weston CJ; O'Shea C; Townend JN; Gehmlich K; Ferro CJ; Denning C; Pavlovic D
    Sci Rep; 2023 Jul; 13(1):12137. PubMed ID: 37495732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E2 is a potent inhibitor of epithelial-to-mesenchymal transition: interaction with hepatocyte growth factor.
    Zhang A; Wang MH; Dong Z; Yang T
    Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1323-31. PubMed ID: 16868306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. K+ channels and the cAMP-PKA pathway modulate TGF-beta1-induced migration of rat vascular myofibroblasts.
    Liu YR; Ye WL; Zeng XM; Ren WH; Zhang YQ; Mei YA
    J Cell Physiol; 2008 Sep; 216(3):835-43. PubMed ID: 18551429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E2 as an inhibitory modulator of fibrogenesis in human lung allografts.
    Walker NM; Badri LN; Wadhwa A; Wettlaufer S; Peters-Golden M; Lama VN
    Am J Respir Crit Care Med; 2012 Jan; 185(1):77-84. PubMed ID: 21940790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct PKA regulatory subunits mediate PGE
    Wettlaufer SH; Penke LR; Okunishi K; Peters-Golden M
    Am J Physiol Lung Cell Mol Physiol; 2017 Oct; 313(4):L722-L731. PubMed ID: 28729346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrogen sulfide suppresses transforming growth factor-β1-induced differentiation of human cardiac fibroblasts into myofibroblasts.
    Zhang Y; Wang J; Li H; Yuan L; Wang L; Wu B; Ge J
    Sci China Life Sci; 2015 Nov; 58(11):1126-34. PubMed ID: 26246380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E₂ and polyenylphosphatidylcholine protect against intestinal fibrosis and regulate myofibroblast function.
    Baird AC; Lloyd F; Lawrance IC
    Dig Dis Sci; 2015 Jun; 60(6):1603-16. PubMed ID: 25630423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smad7 blocks transforming growth factor-β1-induced gingival fibroblast-myofibroblast transition via inhibitory regulation of Smad2 and connective tissue growth factor.
    Sobral LM; Montan PF; Zecchin KG; Martelli-Junior H; Vargas PA; Graner E; Coletta RD
    J Periodontol; 2011 Apr; 82(4):642-51. PubMed ID: 21054221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrins αvβ5 and αvβ3 promote latent TGF-β1 activation by human cardiac fibroblast contraction.
    Sarrazy V; Koehler A; Chow ML; Zimina E; Li CX; Kato H; Caldarone CA; Hinz B
    Cardiovasc Res; 2014 Jun; 102(3):407-17. PubMed ID: 24639195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ac-SDKP inhibits transforming growth factor-beta1-induced differentiation of human cardiac fibroblasts into myofibroblasts.
    Peng H; Carretero OA; Peterson EL; Rhaleb NE
    Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1357-64. PubMed ID: 20154264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.